JBM (Healthcare) Ltd. (HK:2161) has released an update.
JBM (Healthcare) Limited has reported a significant increase in annual financial performance for the year ended March 31, 2024, with a 24.6% rise in revenue to HK$648.4 million and a remarkable 149.5% surge in profit attributable to shareholders, reaching HK$130.5 million. Operational profit doubled, climbing to HK$174.2 million, and the company has proposed a generous final dividend of HK7.5 cents per Share, more than double the previous year’s total dividend.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.
